Toby Mak are most popular:
- within Antitrust/Competition Law topic(s)
- with Finance and Tax Executives and Inhouse Counsel
- in European Union
- with readers working within the Pharmaceuticals & BioTech industries
Toby's Nov 2022 version of "The "Unofficial" CN Orange Book user guide for pharmaceutical patents".
This is out at the IPO Journal, and is available at the link below:
This Nov 2022 version has the following updates:
- Inclusion of data in Nov 2022, including the number of entries in the "CN Orange Book", and updates on patent linkage declarations filed.
- Discussion of the first drug patent linkage appeal decision issued by the CN Supreme Court in Aug 2022.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
